Medical/Pharmaceuticals

FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical Trials Of CoviDTH

VANCOUVER, British Columbia, July 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTCQB: BVAXF)("BioVaxys"), is pleased to announce today that the US Food and Drug Administration ("FDA") has provided its official Written Response to the Company's request for a Pre-IN...

2021-07-22 21:50 7517

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack, Latest Addition to Ortho's Critical Care Blood Testing Menu

RARITAN, N.J., July 22, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics  (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho's VITROS® Critical Care menu, is now ...

2021-07-22 21:00 7003

Mentice publishes the company's interim report for the period January-June 2021

- Mentice delivers record level of sales for the second quarter and first half year STOCKHOLM, July 22, 2021 /PRNewswire/ -- Second quarter (April–June 2021) and first half year (January-June 2021) * Order intake amounted to 40.2 (28.4) MSEK for the second quarter and 80.1 (60.9) MSEK for th...

2021-07-22 15:25 1043

Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB-3115 (Proposed Biosimilar to Ustekinumab)

Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high quality medicines by entering into an exclusive license agreement AHMEDABAD, India, July 22, 2021 /PRNewswire/ -- Intas Pharmaceuticals Ltd continues to pledge their commitment to increasing access to high...

2021-07-22 13:00 1021

Menarini Asia-Pacific strengthens Men's Health portfolio in China with acquisition of Cialis(R) (Tadalafil) from Lilly

* Acquisition of Cialis® in the People's Republic of China to bolster Menarini's Men's Health portfolio and drive multichannel coverage * This is a significant milestone for Menarini Asia operations as it commemorates its 10th anniversary of being established in 13 major healthcare markets in...

2021-07-22 10:00 1381

Antengene Announces The Approval by Human Research Ethics Committee in Australia and to Start the Phase 1 Trial of ATG-101 (the first PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma

SHANGHAI and HONG KONG, July 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-07-22 09:27 1062

Joysbio's COVID-19 RAPID tests detect NEW SARS-COV-2 variants

TIANJIN, China, July 22, 2021 /PRNewswire/ -- Joysbio, one of the world's leading manufacturers of lateral flow rapid test kits, has proven that their SARS-CoV-2 (COVID-19) antigen tests can detect new variants, including the Delta variant that's sweeping the world. With over 100 million tests so...

2021-07-22 08:37 767

China NMPA Approves Phase III Clinical Trial of ASC40 Combined with Bevacizumab for Treatment of Patients with Recurrent Glioblastoma

HANGZHOU, China and SHAOXING, China, July 22, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Phase III clinical trial application of ASC40 combined with Bevacizumab for treatment of patients w...

2021-07-22 08:30 1027

Sensor Technologies for Pressure Injury Prevention Improve Outcomes and Operational Efficiency for Hospitals

New solutions deliver value to hospitals by improving patient care through increased adherence to patient repositioning protocols, according to providers surveyed by Frost & Sullivan SANTA CLARA, Calif., July 22, 2021 /PRNewswire/ -- Even as the incidence of many other healthcare complications i...

2021-07-22 00:30 873

AnchorDx's Non-invasive Bladder Cancer Early Detection Test, UriFind, Earns "Breakthrough Device Designation" from FDA

GUANGZHOU, China, July 21, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, onJuly 13, 2021, was awarded aBreakthrough Device Designation ("BTD")[1] by the US Food and Drug Administration (FDA) for UriFind (or "the Test"), an early detect...

2021-07-21 21:02 1015

ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.

GOLDEN, Colo., July 21, 2021 /PRNewswire/ -- ArcScan, Inc., the developer of state-of-the-art ophthalmic ultrasound imaging device "ArcScan Insight® 100, " headquartered inGolden, Colorado, announces the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. ("Hao...

2021-07-21 20:33 7308

Ascentage Pharma's MDM2-p53 Inhibitor APG-115 (Alrizomadlin) Granted an Orphan Drug Designation by the FDA for the Treatment of Stage IIB-IV Melanoma, Marking the Twelfth Obtained by the Company

SUZHOU, China and ROCKVILLE, Md., July 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Administration (F...

2021-07-21 18:37 2343

Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution

LONDON, July 21, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of theCortellis Supply Chain Network™, a part of the Cortellis suite of life science intelligence soluti...

2021-07-21 16:05 7435

Notice to the Annual General Meeting of Elekta AB (publ)

STOCKHOLM, July 21, 2021 /PRNewswire/ -- The shareholders of Elekta AB (publ), reg. no 556170-4015 are hereby convened to the Annual General Meeting to be held on Wednesday25 August 2021. Due to the coronavirus pandemic, the Board of Directors has decided that the Meeting should be conducted wit...

2021-07-21 15:06 7379

Knowledge Catalyst to Power Paspor Sehat in issuing Digital Health Credentials in Indonesia for Travelers

SINGAPORE, July 21, 2021 /PRNewswire/ -- Knowledge Catalyst, a recognized provider of Digital Health Credentials, also known as HealthCerts inSingapore, is proud to announce its partnership with Paspor Sehat, a recognized provider of the Electronic Health Alert Card (e-HAC) solution inIndonesi...

2021-07-21 14:00 839

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome

Extracellular Vesicle Isolate Product ExoFlo Shows Strong Potential to Treat COVID-19, Post-Acute COVID-19 Syndrome, and Chronic Post-COVID-19 Syndrome; 60-patient trial to be conducted nationally at ambulatory infusion sites AUSTIN, Texas, July 21, 2021 /PRNewswire/ -- Direct Biologics, a marke...

2021-07-21 05:44 817

ExoFlo™ From Direct Biologics Fulfills Urgent Medical Need in COVID-19 Treatment

Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) AUSTIN, Texas, July 21, 2021 /PRNewswire/ -- As intensive care units across the country fill to capacity, hospital beds are in dangero...

2021-07-21 03:43 1034

Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncology

LEUVEN, Belgium, July 20, 2021 /PRNewswire/ -- Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the longstanding partnership in the field of oncology. In the past years, both parties have successful...

2021-07-20 22:54 11531

Interaxon Partners with Celéri Health to Validate Chronic Pain Intervention

TORONTO, July 20, 2021 /PRNewswire/ -- Interaxon, along with Celéri Health and pain expert Dr.Ronald D. Siegel, is testing a therapeutic intervention to help people better manage their chronic and acute pain. With the prevalence of pain and its multidimensional repercussions, this non-opioid alte...

2021-07-20 21:00 671

Everest Medicines Announces Strategic Collaboration with MediTrust Health Co., Ltd to Develop Novel Payment Solutions for Patients in China

SHANGHAI, July 20, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater C...

2021-07-20 18:42 2617
12345 ... 264